DOSSIER · 13F-HR · Q3 2026

Avoro Capital Advisors LLC

$9.7B in tracked AUM across 30 positions as of Q3 2026.

AC
CIK 0001633313 · last filed Sep 30, 2026
Total AUM
$9.7B
as of Q3 2026
Holdings
30
+4 QoQ
positions
Whale Score
84
84
strong
Activity
22
+5 new, −1 sold
changes this Q
AI Analysis · Q3 2026

Avoro Capital Advisors LLC filed its latest 13F-HR for Q3 2026. 22 position changes this quarter — 5 new, 1 exited, 1 added, 15 trimmed.

Quarter at a glance — Q3 2026

22 material changes this filing.

TRIM
CELCCELCUITY INC
-1.9M sh
$-236M
1.2%
TRIM
K08588103ASCENDIS PHARMA A/S
-61K sh
$-213M
11.9%
TRIM
ARWRARROWHEAD PHARMACEUTICALS INC
-356K sh
$-206M
7.4%
TRIM
XENEXENON PHARMACEUTICALS INC
-278K sh
$-144M
2.1%
TRIM
CYTKCYTOKINETICS INC
-100K sh
$-103M
3.3%
EXIT
GLTODAMORA THERAPEUTICS INC
-3.8M sh
$-98M
—
NEW
G2646Y104DAMORA THERAPEUTICS INC
+3.8M sh
+$81M
0.8%

Top 10 holdings

By portfolio weight as of Q3 2026. Source: SEC EDGAR 13F-HR filings.

#HoldingValueSharesWeight
01
UTHR
UNITED THERAPEUTICS CORP
$1.5B2.8M15.4%
02
K08588103
ASCENDIS PHARMA A/S
$1.2B5.0M11.9%
03
KRYS
KRYSTAL BIOTECH INC
$961M2.9M9.9%
04
ARGX
ARGENX SE
$959M1.0M9.9%
05
MDGL
MADRIGAL PHARMACEUTICALS INC
$924M1.8M9.5%
06
KYMR
KYMERA THERAPEUTICS INC
$836M7.5M8.6%
07
ARWR
ARROWHEAD PHARMACEUTICALS INC
$720M11.0M7.4%
08
RVMD
REVOLUTION MEDICINES INC
$440M2.1M4.5%
09
CYTK
CYTOKINETICS INC
$323M4.9M3.3%
10
DFTX
DEFINIUM THERAPEUTICS INC
$268M7.0M2.8%

Filing history

2026Q3Sep 30
$9.7B▼ 13.0%
30 positionsView →
2026Q2Jun 30
$11.1B▲ 9.6%
26 positionsView →
2026Q1Mar 31
$10.2B▼ 0.1%
33 positionsView →
2025Q4Dec 31
$10.2B▲ 93.0%
34 positionsView →
2025Q3Sep 30
$5.3B▼ 7.7%
22 positionsLocked
2025Q2Jun 30
$5.7B▼ 10.9%
30 positionsLocked
2025Q1Mar 31
$6.4B▼ 9.4%
33 positionsLocked
2024Q4Dec 31
$7.1B▲ 3.1%
39 positionsLocked
2024Q3Sep 30
$6.9B▼ 8.7%
36 positionsLocked
2024Q2Jun 30
$7.5B▼ 12.4%
41 positionsLocked
2024Q1Mar 31
$8.6B▲ 18.4%
46 positionsLocked
2023Q4Dec 31
$7.2B▲ 12.9%
42 positionsLocked
Showing 12 of 45